Venous thromboembolism – prevalence and risk factors in chronic venous disease patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73580176" target="_blank" >RIV/61989592:15110/17:73580176 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00098892:_____/17:N0000097

Výsledek na webu

<a href="http://dx.doi.org/10.1177/0268355516633392" target="_blank" >http://dx.doi.org/10.1177/0268355516633392</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1177/0268355516633392" target="_blank" >10.1177/0268355516633392</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Venous thromboembolism – prevalence and risk factors in chronic venous disease patients

Popis výsledku v původním jazyce

Aims: This study was aimed to investigate the prevalence of venous thromboembolism in patients with chronic venous disease and the impact of some intrinsic and extrinsic risk factors. Methods: A retrospective study on 641 outpatients (489 women) with primary chronic venous disease (C0–C6). The prevalence of venous thromboembolism was evaluated according to sex, age, BMI, the presence of 1 first-degree siblings diagnosed with venous thromboembolism, CEAP clinical class, smoking and the use of hormone therapy. Conclusions: The 5% prevalence of venous thromboembolism episodes in patients was comparable with the prevalence of venous thromboembolism in the general European population. Age 70 years and obesity were strongly associated with an occurrence of venous thromboembolism. Obese patients with chronic venous disease were at higher risk for venous thromboembolism than obese people in the general population. A family history of venous thromboembolism, smoking and estrogens alone or in combination were not revealed as significant risk factors.

Název v anglickém jazyce

Venous thromboembolism – prevalence and risk factors in chronic venous disease patients

Popis výsledku anglicky

Aims: This study was aimed to investigate the prevalence of venous thromboembolism in patients with chronic venous disease and the impact of some intrinsic and extrinsic risk factors. Methods: A retrospective study on 641 outpatients (489 women) with primary chronic venous disease (C0–C6). The prevalence of venous thromboembolism was evaluated according to sex, age, BMI, the presence of 1 first-degree siblings diagnosed with venous thromboembolism, CEAP clinical class, smoking and the use of hormone therapy. Conclusions: The 5% prevalence of venous thromboembolism episodes in patients was comparable with the prevalence of venous thromboembolism in the general European population. Age 70 years and obesity were strongly associated with an occurrence of venous thromboembolism. Obese patients with chronic venous disease were at higher risk for venous thromboembolism than obese people in the general population. A family history of venous thromboembolism, smoking and estrogens alone or in combination were not revealed as significant risk factors.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Phlebology

ISSN

0268-3555

e-ISSN

—

Svazek periodika

32

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

6

Strana od-do

135-140

Kód UT WoS článku

000400098400009

EID výsledku v databázi Scopus

—